Cipla Limited (NSE:CIPLA)
1,325.00
+3.80 (0.29%)
Mar 9, 2026, 3:30 PM IST
Cipla Revenue
Cipla had revenue of 69.63B INR in the quarter ending December 31, 2025, with 0.02% growth. This brings the company's revenue in the last twelve months to 279.67B, up 4.67% year-over-year. In the fiscal year ending March 31, 2025, Cipla had annual revenue of 272.67B with 6.78% growth.
Revenue (ttm)
279.67B
Revenue Growth
+4.67%
P/S Ratio
3.82
Revenue / Employee
9.23M
Employees
30,313
Market Cap
1,067.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 272.67B | 17.31B | 6.78% |
| Mar 31, 2024 | 255.37B | 29.77B | 13.20% |
| Mar 31, 2023 | 225.59B | 8.51B | 3.92% |
| Mar 31, 2022 | 217.08B | 25.87B | 13.53% |
| Mar 31, 2021 | 191.21B | 20.40B | 11.94% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zydus Lifesciences | 260.89B |
| Mankind Pharma | 139.14B |
| Aurobindo Pharma | 331.82B |
| Divi's Laboratories | 103.14B |
| Alkem Laboratories | 142.53B |
| Glenmark Pharmaceuticals | 165.10B |
| Laurus Labs | 67.22B |
| Ipca Laboratories | 95.06B |
Cipla News
- 5 days ago - Top Stocks To Buy/Sell Today: HAL, Cipla, Godrej Properties, Aster DM, Ultratech Cement, Adani Ports besides others in focus - Business Upturn
- 7 days ago - Cipla forms 60:40 JV with Kemwell Biopharma to develop and commercialise biologic products - Business Upturn
- 10 days ago - Pharma sector stocks today, Feb 27: Dr. Reddys Lab down 1.14%, Cipla falls 1.04%, Natco Pharma up 1.09% - Business Upturn
- 14 days ago - Cipla shares fall over 2% after USFDA classifies Greece facility inspection as OAI - Business Upturn
- 14 days ago - Top stocks to watch today – February 23: Axis Bank, UPL, Vedanta, Adani Ports, SBI Life, NHPC, IDFC First, Cipla and more - Business Upturn
- 25 days ago - Nifty 50 top losers today, Feb 12: Cipla, Adani Enterprises, Maruti Suzuki India, INDIGO, Adani Ports and more - Business Upturn
- 4 weeks ago - Cipla Launches Win Over Weight Campaign, Igniting a National Conversation on Obesity Care in India - Business Upturn
- 5 weeks ago - Nifty 50 top losers today, Feb 2: Shriram Finance, Axis Bank, Max Healthcare, Infosys, Cipla and more - Business Upturn